Evidence map›Paper›PMID 21873430›Full record

ArticleThe Journal of biological chemistry2011

The E-box binding factors Max/Mnt, MITF, and USF1 act coordinately with FoxO to regulate expression of proapoptotic and cell cycle control genes by phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3 signaling.

Jolyon Terragni, Gauri Nayak, Swati Banerjee, Jose-Luis Medrano, Julie R Graham, James F Brennan, Sean Sepulveda, Geoffrey M Cooper

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Research square · 2023
    Article
  4. Article
  5. FTO Alleviates CdClInternational journal of molecular sciences · 2022
    Article
  6. Article
  7. Review
  8. Article
  9. MYC-Associated Factor MAX is a Regulator of the Circadian Clock.International journal of molecular sciences · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. MITF in melanoma: mechanisms behind its expression and activity.Cellular and molecular life sciences : CMLS · 2015
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jolyon TerragniDepartment of Biology, Boston University, Boston, Massachusetts 02215, USA.
Gauri Nayak
Swati Banerjee
Jose-Luis Medrano
Julie R Graham
James F Brennan
Sean Sepulveda
Geoffrey M Cooper
Boston University · US

Funding

Regulation of apoptosis by PI 3-kinase/Akt signalingR01CA018689 · NCI · DANA-FARBER CANCER INSTITUTE · PI COOPER, GEOFFREY M · 1985 to 2012
$6.2M
NCI NIH HHS R01 CA018689NCI NIH HHS R01 CA18689
6 · The paper itself

Abstract

Phosphatidylinositol (PI) 3-kinase/Akt signaling plays a critical role in cell proliferation and survival, partly by regulation of FoxO transcription factors. Previous work using global expression profiling indicated that inhibition of PI 3-kinase in proliferating cells led to induction of genes that promote cell cycle arrest and apoptosis. The upstream regulatory regions of these genes had binding sites not only for FoxO, but also for Myc/Max transcription factors. In the present study, we have addressed the role of Myc family members and related E-box-binding proteins in the regulation of these genes. Chromatin immunoprecipitations and RNA interference indicated that transcription was repressed by Max-Mnt-Sin3a-histone deacetylase complexes in proliferating cells. Inhibition of PI 3-kinase led to a loss of Max/Mnt binding and transcriptional induction by MITF and USF1, as well as FoxO. Both MITF and USF1 were activated by glycogen synthase kinase (GSK) 3, with GSK3 phosphorylation sites on USF1 identified as the previously described activating site threonine 153 as well as serine 186. siRNA against MITF as well as against FoxO3a protected cells from apoptosis following PI 3-kinase inhibition. These results define a novel E-box-regulated network that functions coordinately with FoxO to regulate transcription of apoptotic and cell cycle regulatory genes downstream of PI 3-kinase/Akt/GSK3 signaling.

Indexed as

Apoptosis Regulatory ProteinsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCell CycleCell Line, TumorForkhead Transcription FactorsGene Expression RegulationGlycogen Synthase Kinase 3HumansMicrophthalmia-Associated Transcription FactorPhosphatidylinositol 3-KinasesPhosphorylationProto-Oncogene Proteins c-aktRepressor ProteinsRNA, Small InterferingSignal TransductionSin3 Histone Deacetylase and Corepressor ComplexApoptosis Regulatory ProteinsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsForkhead Transcription FactorsGlycogen Synthase Kinase 3MAX protein, humanMicrophthalmia-Associated Transcription FactorMITF protein, humanPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRepressor ProteinsRNA, Small InterferingSIN3A transcription factorSin3 Histone Deacetylase and Corepressor ComplexUpstream Stimulatory FactorsUSF1 protein, human

Identifiers

PMID21873430
PMCPMC3196102
OpenAlexW2052128154

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.